CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)	Total	Preferred Stock	Common Stock	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)	Noncontrolling Interest
Balance, shares at Jun. 30, 2020			10,222,223
Balance, amount at Jun. 30, 2020	$ 2,179,381	$ 0	$ 10,223	$ 7,314,341	$ (7,098,984)	$ 1,953,801
Conversion of Trunano subsidiary stock into Grove common stock, shares			1,277,778
Conversion of Trunano subsidiary stock into Grove common stock, amount	0	0	$ 1,278	1,952,523	0	(1,953,801)
Issuance of common stock for acquisition of Infusionz, shares			222,223
Issuance of common stock for acquisition of Infusionz, amount	340,000	0	$ 223	339,777	0	0
Issuance of common stock for acquisition costs, shares			83,334
Issuance of common stock for acquisition costs, amount	127,500	0	$ 83	127,417	0	0
Stock based compensation	93,193	0	0	93,193	0
Net loss	(809,073)	0	$ 0	0	(809,073)	0
Balance, shares at Sep. 30, 2020			11,805,558
Balance, amount at Sep. 30, 2020	1,931,001	0	$ 11,807	9,827,251	(7,908,057)	0
Balance, shares at Jun. 30, 2020			10,222,223
Balance, amount at Jun. 30, 2020	2,179,381	0	$ 10,223	7,314,341	(7,098,984)	1,953,801
Net loss	$ (706,553)
Balance, shares at Dec. 31, 2020	83,334		11,906,947
Balance, amount at Dec. 31, 2020	$ 2,322,771	0	$ 11,907	10,116,401	(7,805,537)	0
Balance, shares at Sep. 30, 2020			11,805,558
Balance, amount at Sep. 30, 2020	1,931,001	0	$ 11,807	9,827,251	(7,908,057)	0
Issuance of common stock for acquisition of Infusionz, shares			101,389
Issuance of common stock for acquisition of Infusionz, amount	155,125	0	$ 100	155,025	0	0
Stock based compensation	134,125	0	0	134,125	0
Net loss	$ 102,520	0	$ 0	0	102,520	0
Balance, shares at Dec. 31, 2020	83,334		11,906,947
Balance, amount at Dec. 31, 2020	$ 2,322,771	$ 0	$ 11,907	10,116,401	(7,805,537)	0
Balance, shares at Jun. 30, 2021		500,000	15,262,394
Balance, amount at Jun. 30, 2021	21,217,973	$ 500	$ 15,262	25,372,247	(4,170,036)	0
Issuance of common stock for acquisition of Infusionz, shares			306,945
Issuance of common stock for acquisition of Infusionz, amount	1,764,876	0	$ 307	1,764,569	0	0
Issuance of common stock for acquisition costs, shares			7,000
Issuance of common stock for acquisition costs, amount	33,740	0	$ 7	33,733	0	0
Stock based compensation	593,098	0	0	593,098	0	0
Net loss	511,711	0	$ 0	0	511,711	0
Issuance of common stock for acquisition of VitaMedica, shares			100,000
Issuance of common stock for acquisition of VitaMedica, amount	482,000	0	$ 100	481,900	0	0
Issuance of common stock for services, shares			35,000
Issuance of common stock for services, amount	175,000	$ 0	$ 35	174,965	0	0
Balance, shares at Sep. 30, 2021		500,000	15,711,339
Balance, amount at Sep. 30, 2021	24,778,398	$ 500	$ 15,711	28,420,512	(3,658,325)	0
Balance, shares at Jun. 30, 2021		500,000	15,262,394
Balance, amount at Jun. 30, 2021	21,217,973	$ 500	$ 15,262	25,372,247	(4,170,036)	0
Net loss	576,544
Balance, shares at Dec. 31, 2021		500,000	16,378,006
Balance, amount at Dec. 31, 2021	29,520,686	$ 500	$ 16,378	33,097,300	(3,593,492)	0
Balance, shares at Sep. 30, 2021		500,000	15,711,339
Balance, amount at Sep. 30, 2021	24,778,398	$ 500	$ 15,711	28,420,512	(3,658,325)	0
Stock based compensation	677,455	0	0	677,455	0	0
Net loss	64,833	0	$ 0	0	64,833	0
Issuance of common stock for acquisition of Interactive Offers, shares			666,667
Issuance of common stock for acquisition of Interactive Offers, amount	4,000,000	$ 0	$ 667	3,999,333	0	0
Balance, shares at Dec. 31, 2021		500,000	16,378,006
Balance, amount at Dec. 31, 2021	$ 29,520,686	$ 500	$ 16,378	$ 33,097,300	$ (3,593,492)	$ 0